Search
01/01/2023
Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort
Rojo-López M.I., Bermúdez-López M., Castro E., Farràs C., Torres G., Pamplona R., Lecube A., Valdivielso J.M., Fernández E., Julve J., Castelblanco E., Franch-Nadal J., Alonso N., Granado-Casas M., Mauricio D., Miquel E., Ortega M., Barbé F., González J., Barril S., Sánchez-de-la-Torre M., Portero-Otín M., Jové M., Hernández M., Rius F., Godoy P., Alonso M.M.. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4.900(Q1/2D).
01/01/2023
Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study
Dieberger A.M., Obermayer-Pietsch B., Harreiter J., Desoye G., van Poppel M.N.M., Simmons D., Corcoy R., Perez J.M.A., Kautzky-Willer A., Damm P., Mathiesen E., Jensen D.M., Andersen L.L.T., Dunne F., Lapolla A., Dalfra M.G., Bertolotto A., Jelsma J.G.M., Galjaard S., Wender-Ozegowska E., Zawiejska A., Hill D., Devlieger R., Snoek F.J.. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9)DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4.200(Q1/3D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.02.002. PMID:37268528. IF:1.800(Q3/8D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?
Velilla T.A., Guijarro C., Ruiz R.C., Piñero M.R., Marcos J.F.V., Pérez A.P., López M.A.B., López A.M., Donaire J.A.G., Obaya J.C., Guerra L.C., Carratalá V.P., Cabello I.E., Lazo M.S., Rodrigo M.M.C., Prieto J.M.M., Doblas J.J.G., Soto A.B.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?. Neurology Perspectives. 2023; 3(2)DOI:10.1016/j.neurop.2023.100126. PMID:. IF:(Q/D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2)DOI:10.1016/j.rccl.2022.11.004. PMID:. IF:(Q/D).
01/01/2023
Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital
Bellido V., Freckman G., Pérez A., Galindo R.J.. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11)DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3.700(Q2/4D).
01/01/2023
NAD+ Precursors: A Physiological Reboot?
Niño-Narvión J., Camacho M., Julve J.. NAD+ Precursors: A Physiological Reboot?. Nutrients. 2023; 15(20)DOI:10.3390/nu15204479. PMID:. IF:(Q/D).
01/01/2023
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Jr, ARO, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. ADVANCES IN THERAPY. 2023; 40(2)DOI:10.1007/s12325-022-02360-6. PMID:36502449. IF:3.400(Q2/3D).
01/01/2023
Quality of life in pituitary diseases
Webb S.M., Valassi E.. Quality of life in pituitary diseases. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.03.001. PMID:. IF:(Q/D).
01/01/2023
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
Reiniš J., Petrenko O., Simbrunner B., Hofer B.S., Schepis F., Scoppettuolo M., Saltini D., Indulti F., Guasconi T., Albillos A., Téllez L., Villanueva C., Brujats A., Garcia-Pagan J.C., Perez-Campuzano V., Hernández-Gea V., Rautou P.-E., Moga L., Vanwolleghem T., Kwanten W.J., Francque S., Trebicka J., Gu W., Ferstl P.G., Gluud L.L., Bendtsen F., Møller S., Kubicek S., Mandorfer M., Reiberger T.. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis. JOURNAL OF HEPATOLOGY. 2023; 78(2)DOI:10.1016/j.jhep.2022.09.012. PMID:36152767. IF:26.800(Q1/1D).
01/01/2023
SEED Consensus Document on SpyGlass-DS
Sánchez-Ocaña R., Foruny Olcina J.R., Vila Costas J., Gallego Rojo F., Jiménez Pérez J., Domínguez-Muñoz E., González Huix F., Pons Beltrán V., Gornals Soler J., Sánchez Hernández E., Gómez Oliva C., Dolz Abadía C., Aparicio Tormo J.R.. SEED Consensus Document on SpyGlass-DS. Gastroenterologia y Hepatologia. 2023; 46(1)DOI:10.1016/j.gastrohep.2022.08.012. PMID:36179947. IF:2.200(Q3/6D).
01/01/2023
Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022
Carrión J.A., Graupera I., Vergara M., Morillas R.M., Pericàs J.M., Poca M., Amador A., Fernández R., Monllor T., Muñoz L., Bartres C., Genescà J., Ginés P., Forns X.. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022. Gastroenterologia y Hepatologia. 2023; 46(9)DOI:10.1016/j.gastrohep.2022.11.005. PMID:36435378. IF:2.200(Q3/6D).
01/01/2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
Chaparro M., Acosta D., Rodríguez C., Mesonero F., Vicuña M., Barreiro-De Acosta M., Fernández-Clotet A., Hernández Martínez Á., Arroyo M., Vera I., Ruiz-Cerulla A., Sicilia B., Cabello Tapia M.J., Muñoz Villafranca C., Castro-Poceiro J., Martínez Cadilla J., Sierra-Ausín M., Vázquez Morón J.M., Vicente Lidón R., Bermejo F., Royo V., Calafat M., González-Muñoza C., Leo Carnerero E., Manceñido Marcos N., Torrealba L., Alonso-Galán H., Benítez J.M., Ber Nieto Y., Diz-Lois Palomares M.T., García M.J., Muñoz J.F., Armesto González E.M., Calvet X., Hernández-Camba A., Madrigal Domínguez R.E., Menchén L., Pérez Calle J.L., Piqueras M., Dueñas Sadornil C., Botella B., Martínez-Pérez T.D.J., Ramos L., Rodríguez-Grau M.C., San Miguel E., Fernández Forcelledo J.L., Fradejas Salazar P.M., García-Sepulcre M., Gutiérrez A., Llaó J., Sesé Abizanda E., Boscá-Watts M., Iyo E., Keco-Huerga A., Martínez Bonil C., Peña González E., Pérez-Galindo P., Varela P., Gisbert J.P.. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(7)DOI:10.14309/ajg.0000000000002145. PMID:36716287. IF:8.500(Q1/1D).
01/01/2023
Carvedilol, probably the ß-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!
Villanueva C., Tripathi D.. Carvedilol, probably the ß-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!. LIVER INTERNATIONAL. 2023; 43(6)DOI:10.1111/liv.15582. PMID:37166136. IF:6.000(Q1/2D).
01/01/2023
Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing
Torrico M.C., Fernández-Arévalo A., Ballart C., Solano M., Rojas E., Abras A., Gonzales F., Arnau A., Tebar S., Llovet T., Lozano D., Ariza-Vioque E., Gascón J., Picado A., Torrico F., Munoz, C, Gállego M.. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing. Microbiology Spectrum. 2023; 11(1)DOI:10.1128/spectrum.03477-22. PMID:36633426. IF:3.700(Q2/4D).
01/01/2023
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
Becerra-Aparicio F., Gómez-Zorrilla S., Hernández-García M., Gijón D., Siverio A., Berbel D., Sánchez-Carrillo C., Cercenado E., Rivera A., de Malet A., Xercavins M., Ruiz de Gopegui E., Canoura-Fernández L., Martínez J.A., Seral C., Del Pozo J.L., Cotarelo M., Díaz-Regañón J., Cantón R., Oliver A., Horcajada J.P., Ruiz-Garbajosa P.. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad234. PMID:37533351. IF:3.900(Q1/3D).
01/01/2023
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
Sojo-Dorado J., López-Hernández I., Hernández-Torres A., Retamar-Gentil P., Merino De Lucas E., Escolà-Verge L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Álvarez R.M., Dueñas C.J., Calvo-Montes J., Lecuona M., Pomar V., Borreguero I., Palomo-Jimenez V., Docobo-Perez F., Pascual Á., Rodríguez-Baño J.. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(7)DOI:10.1093/jac/dkad147. PMID:37260299. IF:3.900(Q1/3D).
01/01/2023
The slowdown of new infections by human retroviruses has reached a plateau in Spain
de Mendoza C., Carrizo P., Sauleda S., Richart A., Rando A., Miró E., Benito R., Ayerdi O., Encinas B., Aguilera A., Reina G., Rojo S., González R., Fernández-Ruiz M., Liendo P., Montiel N., Roc L., Treviño A., Pozuelo M.J., Soriano V.. The slowdown of new infections by human retroviruses has reached a plateau in Spain. JOURNAL OF MEDICAL VIROLOGY. 2023; 95(5)DOI:10.1002/jmv.28779. PMID:37212269. IF:6.800(Q1/1D).
01/01/2023
Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study
Pérez-Recio S., Grijota-Camino M.D., Anibarro L., Rabuñal-Rey R., Sabria J., Gijón-Vidaurreta P., Pomar V., García-Gasalla M., Domínguez-Castellano Á., Trigo M., Santos M.J., Cebollero A., Rodríguez S., Moga E., Penas-Truque A., Martos C., Ruiz-Serrano M.J., Garcia-De-Cara E.I., Alcaide F., Santin M.. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. PLoS One. 2023; 18(8)DOI:10.1371/journal.pone.0285917. PMID:37647315. IF:2.900(Q1/3D).
01/01/2023
Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study
Batlle M., Badia J.M., Hernández S., Grau S., Padulles A., Boix-Palop L., Giménez-Pérez M., Ferrer R., Calbo E., Limón E., Pujol M., Horcajada J.P., Smithson A., Ros N.B., Gomila-Grange A., Pomar V., Toboso S.H., Murgadella-Sancho A., Perez-Hita A.O., Temple M.D., Molpeceres S.V., Pardo D.R., Río A.D., Luque M.F.S., Blanco N.V., Acedo S.O., Guitart S.S., Nicolas E.M., Noblia-Gigena L.B., Pérez O.D.R., Rodriguez M.P.G., Barcons I.A., Serra N.J., Calva L.C., Lérida A., Torras S.G., Martínez L.H., Miñambres C., Matellane J.M., Jofre C.S., Estada S.B., Carrascosa M.C., Mota S.T., Barrena D.S.. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; 62(5)DOI:10.1016/j.ijantimicag.2023.106943. PMID:37541529. IF:4.900(Q1/2D).
01/01/2023
Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT
Benito N., Martínez-Pastor J.C., Lora-Tamayo J., Ariza J., Baeza J., Belzunegui-Otano J., Cobo J., del-Toro M.-D., Fontecha C.G., Font-Vizcarra L., Horcajada J.P., Morata L., Murillo O., Nolla J.M., Núñez-Cuadros E., Pigrau C., Portillo M.E., Rodríguez-Pardo D., Sobrino-Díaz B., Saavedra-Lozano J.. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; DOI:10.1016/j.eimc.2023.07.003. PMID:. IF:(Q/D).
01/01/2023
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis
Sainz L., Riera P., Moya P., Bernal S., Casademont J., Díaz-Torné C., Millán A.M., Park H.S., Lasa A., Corominas H.. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1)DOI:10.3390/jpm13010061. PMID:36675722. IF:3.000(Q1/2D).
01/01/2023
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
Colalillo A., Hoffmann-Vold A.-M., Pellicano C., Romaniello A., Gabrielli A., Hachulla E., Smith V., Simeón-Aznar C.-P., Castellví I., Airò P., Truchetet M.-E., Siegert E., Distler O., Rosato E.. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4)DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9.200(Q1/1D).
01/01/2023
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Tasende J.A.P., Baute J.J.B., Joven Ibáñez B., Toniolo E., Ramírez J., Montero N., Pruenza García-Hinojosa C., Serrano García A.. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12030931. PMID:36769579. IF:3.000(Q1/2D).
01/01/2023
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
Jeria-Navarro S., Gomez-Gomez A., Park H.S., Calvo-Aranda E., Corominas H., Pou M.A., Diaz-Torne C.. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3.100(Q1/2D).
01/01/2023
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Narváez J., Aburto M., Seoane-Mato D., Bonilla G., Acosta O., Candelas G., Cano-Jiménez E., Castellví I., González-Ruiz J.M., Corominas H., López-Muñiz B., Martín-López M., Robles-Pérez A., Mena-Vázquez N., Rodríguez-Portal J.A., Ortiz A.M., Sabater-Abad C., Castrejón I., dos Santos R., Garrote-Corral S., Maese J., Silva-Fernández L., Castañeda S., Valenzuela C.. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2)DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:(Q/D).
01/01/2023
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., Marcos A.G.. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1)DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3.400(Q2/3D).
01/01/2023
Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis
Oteo J.A., Corominas H., Escudero R., Fariñas-Guerrero F., García-Moncó J.C., Goenaga M.A., Guillén S., Mascaró J.M., Portillo A.. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1)DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2.600(Q3/6D).
01/01/2023
Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
Crespo-Lessmann A., Curto E., Medina, EFM, Palones E., Soler A.B., Maza S.S., Soto-Retes L., Plaza V.. Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia. Journal of Asthma and Allergy. 2023; 16DOI:10.2147/JAA.S389402. PMID:36699564. IF:3.700(Q1/3D).
01/01/2023
Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
Molina J., Plaza V., Nuevo J., Gutiérrez M., Sicras-Mainar A., Valero A.. Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100232. PMID:37496866. IF:(Q/D).
01/01/2023
Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
Plaza V., Cañete C., Domingo C., Martínez Rivera C., Muñoz X.. Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2022.100231. PMID:37496871. IF:(Q/D).
01/01/2023
Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study
Barroso B., Valverde-Monge M., Alobid I., Olaguibel J.M., Rial M.J., Quirce S., Arismendi E., Barranco P., Betancor D., Bobolea I., Cárdaba B., Cruz Carmona M.J., Curto E., Domínguez-Ortega J., González-Barcala F.J., Martínez-Rivera C., Mahíllo-Fernández I., Muñoz X., Picado C., Plaza V., Rodrigo Muñoz J.M., Soto-Retes L., Valero A., Del Pozo V., Mullol J., Sastre J.. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0812. PMID:35416154. IF:6.700(Q1/2D).
01/01/2023
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Pérez de Llano L., Cisneros C., Domínguez-Ortega J., Martínez-Moragón E., Olaguibel J.M., Plaza V., Quirce S., Dávila I.. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0857. PMID:36040046. IF:6.700(Q1/2D).
01/01/2023
Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids
Gil-Martínez M., Lorente-Sorolla C., Rodrigo-Muñoz J.M., Lendínez M.Á., Núñez-Moreno G., de la Fuente L., Mínguez P., Mahíllo-Fernández I., Sastre J., Valverde-Monge M., Quirce S., Caballero M.L., González-Barcala F.J., Arismendi E., Bobolea I., Valero A., Muñoz X., Cruz M.J., Martínez-Rivera C., Plaza V., Olaguibel J.M., del Pozo V.. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(2)DOI:10.3390/ijms24021611. PMID:36675122. IF:4.900(Q1/3D).
01/01/2023
Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(1)DOI:10.1016/j.arbres.2022.07.011. PMID:35970652. IF:8.700(Q1/1D).
01/01/2023
Economic Consequences of the Overuse of Short-Acting ?-Adrenergic Agonists in the Treatment of Asthma in Spain
Valero A., Molina J., Nuevo J., Simon S., Capel M., Sicras-Mainar A., Sicras-Navarro A., Plaza V.. Economic Consequences of the Overuse of Short-Acting ?-Adrenergic Agonists in the Treatment of Asthma in Spain. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(2)DOI:10.18176/jiaci.0767. PMID:34825651. IF:6.700(Q1/2D).
01/01/2023
Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
Domínguez-Ortega J., Luna-Porta J.A., Olaguibel J.M., Barranco P., Arismendi E., Barroso B., Betancor D., Bobolea I., Caballero M.L., Cárdaba B., Cruz M.J., Curto E., González-Barcala F.J., Losantos-García I., Martínez-Rivera C., Mendez-Brea P., Mullol J., Munoz, X, Picado C., Plaza V., Del Pozo V., Rial M.J., Sastre J., Soto L., Valero A., Valverde-Monge M., Quirce S.. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(4)DOI:10.18176/jiaci.0816. PMID:35503227. IF:6.700(Q1/2D).
01/01/2023
Factors Associated With Large Airway Collapse in Severe Asthma
Martinez Rivera C., Serra Mitjà P., Andreo García F., Crespo-Lessmann A., Solis Solis A.J., Torrego A., Garcia-Olive I., Ramos-Barbón D., Zapata Comas T., Plaza V., Abad J., Rosell A.. Factors Associated With Large Airway Collapse in Severe Asthma. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(9)DOI:10.1016/j.arbres.2023.05.006. PMID:37296031. IF:8.700(Q1/1D).
01/01/2023
Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis
Cobo Sanchez L., Ruiz Herrero C., Cobos I., Bespin J., Gadea C., Cerdá-Cortés P., Palma J., Vicens-Zygmunt V., Bermudo G., Portillo K., Boldova A., Robles A., Arribas J., Figuerola J.A., Blavia R., Moreno A., Castillo D., Villar A., Belmonte Y., Badenes-Bonet D., Zayas D., Suarez-Cuartin G., Garcia-Bellmunt L., Sellarés J., Barril S., Sans J., Serra M., Perich D., Esteban L.L., Esteban L., Balcells E., Gil F., Ruiz E., Fina C., Molina-Molina M.. Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(8)DOI:10.1016/j.arbres.2023.03.008. PMID:37003881. IF:8.700(Q1/1D).
01/01/2023
A Study of the Prevalence of Asthma in the General Population in Spain
Blanco-Aparicio M., García-Río F.J., González-Barcala F.J., Jiménez-Ruiz C.A., Muñoz X., Plaza V., Soto-Campos J.G., Urrutia-Landa I., Almonacid C., Peces-Barba G., Álvarez-Gutiérrez F.J.. A Study of the Prevalence of Asthma in the General Population in Spain. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100245. PMID:37496876. IF:(Q/D).